Obesity
Not recruitingStudy on How Cagrilintide and Semaglutide Help People with Overweight or Obesity Reduce Weight
- Disease:Obesity
- Substances:–
Bulgaria- Participants:18–64 years · 65+ years
- Sponsor:Novo Nordisk A/S
Rare diseases
Investigational molecules
Locations
Ulitsa Emanuil Vaskidovich 51, 1517 Sofia, Bulgaria
Diagnostichno-Konsultativen Tsentar XVIII-Sofia OOD in Sofia, Bulgaria specialises in clinical trials of conditions such as Obesity, and other specialisations. This site conducts important research.
The medical center is at the forefront of weight management and obesity research, focusing on innovative approaches to help individuals achieve sustainable weight loss. The center's research is dedicated to understanding the complex biological, behavioral, and environmental factors contributing to obesity.
By integrating cutting-edge research with clinical practice, the center aims to develop comprehensive treatment plans that address the unique needs of each patient, ultimately improving their quality of life and reducing the risk of obesity-related complications.
Clinical trials registered at this site – none is enrolling right now.
BulgariaGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.